Vítor Camargo Pôrto

Vítor Camargo Pôrto

Auto-generated profile, based on publicly available information

Vítor Camargo Pôrto

Federal University of Health Sciences of Porto Alegre (UFCSPA)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in Journal of Mass Spectrometry
Verified
Journal Article
Open access
Bruno Pereira dos SantosBruno Pereira dos Santos
Bruno Pereira dos Santos
LBLetícia Birk
Letícia Birk
VPVítor Camargo Pôrto
Vítor Camargo Pôrto
SNSabrina Nunes Nascimento
Sabrina Nunes Nascimento
VSViviane Cristina Sebben
Viviane Cristina Sebben
TOTiago Franco de Oliveira
Tiago Franco de Oliveira
The laboratory analysis of new psychoactive substances and related drugs is crucial for accurate clinical and forensic diagnosis of poisonings. Given this, a new LC‐MS/MS method for analyzing hallucinogens, synthetic cathinones, and synthetic cannabinoids in urine was developed. Urine samples were extracted using a liquid–liquid extraction protocol optimized via a multivariate experimental design. An aliquot of 400 μL of urine was enzymatically hydrolyzed with β‐glucuronidase and extracted with 700 μL of ethyl acetate. The resulting extracts were analyzed using LC‐MS/MS, with a total chromatographic run time of 8 min. The method was validated according to the ANSI/ASB Standard 036 guideline and was applied to 24 samples from suspected poisoning cases. The lower limits of quantification ranged from 0.1 to 1 ng/mL. Within‐run and between‐run precision (CV) were < 16%, and bias ranged from −12.8% to 19.8%. Nine of the 20 analytes investigated showed significant ionization suppression or enhancement (> 25%). Only two analytes (2C‐E and 2‐oxo‐3‐OH‐LSD) had a recovery rate lower than 70%. Among the 24 analyzed urine samples, one tested positive for 25B‐NBOH, one for LSD, and two for 2‐oxo‐3‐OH‐LSD. The developed method enables the simultaneous quantification of 20 illicit drugs, serving as an efficient diagnostic tool for clinical and forensic laboratories.

10 June 2026 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
Bruno Pereira dos SantosBruno Pereira dos Santos
Bruno Pereira dos Santos
VPVítor Camargo Pôrto
Vítor Camargo Pôrto
LBLetícia Birk
Letícia Birk
SNSabrina Nunes Do Nascimento
Sabrina Nunes Do Nascimento
VSViviane Cristina Sebben
Viviane Cristina Sebben
TOTiago Franco de Oliveira
Tiago Franco de Oliveira
Ecstasy-type drugs are the most frequently seized synthetic drugs in Brazil, usually containing a mixture of MDMA and its analog MDA. In recent years, an increasing number of samples have been found to contain only MDA, possibly reflecting shifts in the synthetic routes of ecstasy-type substances during the COVID-19 pandemic. However, the exclusive use of MDA remains poorly characterized, and its toxicological profile is still not fully understood. Data from chemical analyses of drug seizures in Rio Grande do Sul, Southern Brazil, were reviewed. In addition, blood and urine samples collected from clinical and forensic cases involving ecstasy use were analyzed by LC-MS/MS. MDA was detected in 31.1% of seized drug samples, surpassing MDMA, which accounted for 25.6%. A marked rise in MDA detections was observed after 2020, peaking at 52.6% of seizures in 2023. In addition, sixteen clinical and four postmortem cases involving MDMA and/or MDA were documented, with MDA predominating from 2021 onwards. The study identified a higher prevalence of MDA compared to MDMA, indicating a shift in ecstasy use patterns in Brazil. This finding underscores the need for robust analytical approaches and sustained toxicological monitoring to support drug surveillance and public health policies.

8 May 2026 in Journal of Ethnicity in Substance Abuse
Verified
Journal Article
Closed access
VPVítor Camargo Pôrto
Vítor Camargo Pôrto
Bruno Pereira dos SantosBruno Pereira dos Santos
Bruno Pereira dos Santos
LBLetícia Birk
Letícia Birk
SNSabrina Nunes Do Nascimento
Sabrina Nunes Do Nascimento
VSViviane Cristina Sebben
Viviane Cristina Sebben
SESarah Eller
Sarah Eller
Drug use affects a significant portion of the Brazilian population, which increases the likelihood of children being exposed to illicit drug environments, making them a particularly vulnerable group. This study describes the profile of illicit drug exposure in children up to 12 years in Rio Grande do Sul state, Brazil, based on emergency cases. Data were collected from suspected intoxication cases attended between 2018 and 2023 in children ≤12 years old. Urine samples were analyzed for cocaine and its metabolites, THC-COOH, and amphetamine-type stimulants using LC-MS/MS. Information about the cases was also collected. Of 286 suspected cases, 32.9% detected at least one illicit drug. Cocaine and its metabolites were the most common (24.8%), followed by THC-COOH (9.4%) and MDA/MDMA (2.1%). Among detected drug cases, 56.4% were male. The mean age was 3.4 ± 3.5 years, with the highest incidence in 1 to 4-year-olds (47.9%). Exposure circumstances included accidental (37.2%), mistreatment/violence (8.5%), and abuse (2.1%). Most exposures occurred at home (58.5%). A notable prevalence of illicit drugs, mainly cocaine, was found. These data show a worrying scenario of drug exposure, primarily involving children aged 1 to 4 years. Above all, it also demonstrates a high frequency of exposure to illicit drugs in their own homes. The findings provide a solid basis for toxicovigilance activities and the development of public health policies aimed at protecting the vulnerable pediatric population.